Testing effectiveness (Phase 2)Ended earlyNCT02935673
What this trial is testing
Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine Regimens in Adult Participants Hospitalized With Respiratory Syncytial Virus
Who this might be right for
Respiratory Syncytial Viruses
Janssen Research & Development, LLC 49